[Form 4] DBV Technologies S.A. Insider Trading Activity

Rhea-AI Filing Summary

DBV Technologies S.A. (DBVT) reported an equity award to its Chief Commercial Officer on a Form 4 insider filing. On November 21, 2025, the officer received 55,000 ordinary shares through a restricted stock unit (RSU) award and 316,250 employee stock options with an exercise price of $2.9 per share. Both the RSUs and options vest in four equal annual installments starting on November 21, 2026, contingent on continued service. The options expire on November 21, 2035. The ordinary shares may be represented by American Depositary Shares, with each ADS currently representing five ordinary shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Trapp Kevin Michael

(Last) (First) (Middle)

C/O DBV TECHNOLOGIES S.A.

107 AVENUE DE LA REPUBLIQUE

(Street)

CHATILLON I0 92320

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DBV Technologies S.A. [ DBVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares(1)	11/21/2025		A(2)		55,000	A	$0	55,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$2.9(3)	11/21/2025		A		316,250		(4)	11/21/2035	Ordinary Shares	316,250	$0	316,250	D

Explanation of Responses:

1. The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.

2. Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.

3. This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15154 to EURO 1.00 as of November 21, 2025.

4. The option shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.

	/s/ Virginie Boucinha, Attorney-in Fact	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DBV Technologies (DBVT) disclose in this Form 4?

DBV Technologies disclosed that its Chief Commercial Officer acquired 55,000 ordinary shares via a restricted stock unit award and 316,250 employee stock options on November 21, 2025.

How many RSUs did the DBVT Chief Commercial Officer receive and how do they vest?

The officer received 55,000 RSUs, each representing the right to receive one ordinary share. The RSUs vest in four equal annual installments starting on November 21, 2026, subject to continued service.

What are the key terms of the employee stock options reported by DBVT?

The filing reports 316,250 employee stock options with an exercise price of $2.9 per ordinary share. These options vest in four equal annual installments beginning on November 21, 2026 and expire on November 21, 2035.

How was the $2.9 exercise price for the DBVT stock options determined?

The $2.9 exercise price is in U.S. dollars and reflects the conversion of euros to dollars at an exchange rate of $1.15154 to EUR 1.00 as of November 21, 2025.

How are DBV Technologies ordinary shares related to its American Depositary Shares (ADS)?

The filing states that DBV Technologies’ ordinary shares may be represented by American Depositary Shares, and that each ADS currently represents five ordinary shares.

Is the equity reported in this Form 4 held directly or indirectly by the DBVT officer?

The Form 4 indicates that the 55,000 ordinary shares and the 316,250 stock options are held with direct (D) ownership by the reporting person.